Most Recent
ANZ Bank New Zealand has lost its bid to appeal a ruling that common fund orders can be made in class actions, including at an early stage of the proceeding,
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Maurice Blackburn is stuck paying $5.4 million in security in a flex commissions class action against Macquarie, with a judge saying it represents a “business risk willingly undertaken”.
Class action settlements leaped in value last year, with three settlements topping the $200 million mark.
Hino Motors has agreed to pay $87 million to settle a consumer class action alleging it misrepresented that its vehicles met Australian emissions and road standards over a 20-year period.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
A judge has approved a $56 million settlement in a class action alleging Monash IVF destroyed potentially viable embryos, including a $10.6 million payout for the firm that ran the case.
A class action against Toyota Finance has argued it can add new claims that are out of time because Victorian courts cannot factor in the loss of limitations defences in deciding whether to allow amendments.
Johnson & Johnson has been hit with a class action for allegedly pushing ineffective cold and flu medications containing phenylephrine onto customers for decades.